CXCR4 knockdown prevents inflammatory cytokine expression in macrophages by suppressing activation of MAPK and NF-κB signaling pathways
Cited by 74
Related Papers
Sublingual Edaravone Dexborneol for the Treatment of Acute Ischemic Stroke
|JAMA Neurology|2024|97
Chinese expert consensus on intestinal microecology and management of digestive tract complications related to tumor treatment (version 2022)
|Journal of Cancer Research and Therapeutics|2022|35
Soluble lectin‐like oxidized low‐density Lipoproteinreceptor‐1 and recurrent stroke: A nested case–control study
|CNS Neuroscience & Therapeutics|2022|3